176 related articles for article (PubMed ID: 12116052)
21. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
22. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents.
Wang H; Li M; Rhie JK; Hockenbery DM; Covey JM; Zhang R; Hill DL
Cancer Chemother Pharmacol; 2005 Sep; 56(3):291-8. PubMed ID: 15883820
[TBL] [Abstract][Full Text] [Related]
23. P450 induction alters paclitaxel pharmacokinetics and tissue distribution with multiple dosing.
Gustafson DL; Long ME; Bradshaw EL; Merz AL; Kerzic PJ
Cancer Chemother Pharmacol; 2005 Sep; 56(3):248-54. PubMed ID: 15856231
[TBL] [Abstract][Full Text] [Related]
24. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
Kelley JA; Litterst CL; Roth JS; Vistica DT; Poplack DG; Cooney DA; Nadkarni M; Balis FM; Broder S; Johns DG
Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy.
Togami K; Kanehira Y; Tada H
Biopharm Drug Dispos; 2015 May; 36(4):205-15. PubMed ID: 25487063
[TBL] [Abstract][Full Text] [Related]
26. Detection of the non-steroidal anti-inflammatory drug niflumic acid in humans: a combined 19F-MRS in vivo and in vitro study.
Bilecen D; Schulte AC; Kaspar A; Küstermann E; Seelig J; Elverfeldt D; Scheffler K
NMR Biomed; 2003 May; 16(3):144-51. PubMed ID: 12884358
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice.
Anderton MJ; Manson MM; Verschoyle RD; Gescher A; Lamb JH; Farmer PB; Steward WP; Williams ML
Clin Cancer Res; 2004 Aug; 10(15):5233-41. PubMed ID: 15297427
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and tissue distribution of the sesquiterpene alpha-humulene in mice.
Chaves JS; Leal PC; Pianowisky L; Calixto JB
Planta Med; 2008 Nov; 74(14):1678-83. PubMed ID: 18951339
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat.
Teng XW; Davies NM; Fukuda C; Good RL; Fariss MW
Biopharm Drug Dispos; 2005 Jul; 26(5):195-203. PubMed ID: 15900617
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application.
Saghir SA; Frantz SW; Spence MW; Nolan RJ; Lowe ER; Rick DL; Bartels MJ
Food Chem Toxicol; 2007 Oct; 45(10):2047-56. PubMed ID: 17583405
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
32. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
[TBL] [Abstract][Full Text] [Related]
33. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
Ress NB;
Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
[TBL] [Abstract][Full Text] [Related]
34. Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
Li M; Wang H; Hill DL; Stinson S; Veley K; Grossi I; Peggins J; Covey JM; Zhang R
Cancer Chemother Pharmacol; 2006 May; 57(5):607-14. PubMed ID: 16331493
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
[TBL] [Abstract][Full Text] [Related]
36. Metabolism and disposition of 1-bromopropane in rats and mice following inhalation or intravenous administration.
Garner CE; Sumner SC; Davis JG; Burgess JP; Yueh Y; Demeter J; Zhan Q; Valentine J; Jeffcoat AR; Burka LT; Mathews JM
Toxicol Appl Pharmacol; 2006 Aug; 215(1):23-36. PubMed ID: 16513153
[TBL] [Abstract][Full Text] [Related]
37. [Pharmacokinetics and distribution of isotetrandrine in rats].
Sun H; Han GZ; Su CY; Dai SF
Yao Xue Xue Bao; 1990; 25(4):241-6. PubMed ID: 2281784
[TBL] [Abstract][Full Text] [Related]
38. Validation of Large White Pig as an animal model for the study of cannabinoids metabolism: application to the study of THC distribution in tissues.
Brunet B; Doucet C; Venisse N; Hauet T; Hébrard W; Papet Y; Mauco G; Mura P
Forensic Sci Int; 2006 Sep; 161(2-3):169-74. PubMed ID: 16859848
[TBL] [Abstract][Full Text] [Related]
39. Single- and multiple-dose pharmacokinetics of pirfenidone, an antifibrotic agent, in healthy Chinese volunteers.
Shi S; Wu J; Chen H; Chen H; Wu J; Zeng F
J Clin Pharmacol; 2007 Oct; 47(10):1268-76. PubMed ID: 17906160
[TBL] [Abstract][Full Text] [Related]
40. Preclinical evaluation of the pharmacokinetics, brain uptake and metabolism of E121, an antiepileptic enaminone ester, in rats.
Khurana M; Salama NN; Scott KR; Nemieboka NN; Bauer KS; Eddington ND
Biopharm Drug Dispos; 2003 Dec; 24(9):397-407. PubMed ID: 14689468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
